Perrigo Recalls Albuterol Sulfate Inhalers Due to Possible Clogging

September 22, 2020

Perrigo has issued a voluntary recall of all unexpired albuterol sulfate inhalation aerosol to the retail level.

Study Compares Clinical Features of COVID-19 and Seasonal Influenza

September 22, 2020

A new report illuminates the similarities and differences between COVID-19 and seasonal influenza.

Teva Launches 2 New Digital Maintenance Inhalers

September 21, 2020

Teva’s 2 digital inhalers for patients with asthma provide insight into objective inhaler use data.

Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common Cold

September 21, 2020

Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.

Baricitinib Plus Remdesivir Improves Recovery Time for Hospitalized COVID-19

September 15, 2020

Early data from a phase 3 trial showed that baricitinib combined with remdesivir improved recovery in patients hospitalized with COVID-19 compared with remdesivir alone.

FDA Approves New Asthma Indication for Trelegy Ellipta

September 10, 2020

Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta; GlaxoSmithKline) is indicated for the treatment of asthma in patients aged 18 years and older.

Adult Pneumonia Management and Prevention

September 08, 2020

Pharmacists can play an important role in pneumonia management and prevention.

Experts Discuss Race for a COVID-19 Vaccine

August 04, 2020

Three scientists discuss the global race for a COVID-19 vaccine.

International Panel Issues Weak Recommendation for Remdesivir in Severe COVID-19

August 03, 2020

A panel has given a “weak recommendation” for the use of remdesivir in patients with severe coronavirus disease 2019.

FDA Approves Triple Combination Therapy for Maintenance Treatment of COPD

July 28, 2020

Approval was based on trials that reported significantly reduced exacerbation rates compared with dual-combination therapies.